Centre Hospitalier Intercommunal De Mont De Marsan Et Du Pays Des Sources — Clinical Trial Site

39 Registered trials

20 Currently recruiting

Organisation

Centre Hospitalier Intercommunal De Mont De Marsan Et Du Pays Des Sources

Location

Mont-De-Marsan Cedex, France

Identifier

ORG-100042615

Address

Avenue Pierre De Coubertin, Bp 417, 40024, France

Departments

gastro enterology
Gynecologie
hématologie
Hematology
Hematology unit
hépato gastro enterology
Hepato-gastroenterology
Hepatogastroenterology
Maladies Infectieuses
Maladies Infectieuses et Tropicales
Médecine Ambulatoire Oncologie
Médecine Interne
medical oncology
Multipurpose intensive care
Nephrology
Neurology
Oncologie
Oncologie Hématologie
Oncologie médicale
Oncology
Pédiatrie
Pedriatrie
Service d'hématologie
Service d'hématologie clinique
Service de Pneumologie
Surgery

Clinical trials at this site (39)

Search interface

Study of safety and efficacy of Venetoclax in combination with Vidaza (Azacitidine) in higher-risk Chronic Myelomonocytic Leukemia (CMML) Ended

2024-514878-53-00 HMA-naïve, higher-risk (HR, defined as CPSS-mol risk in 4 2023-10-04
AITIK-Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System Ended

2024-515479-36-00 Chronic Myeloid Leukemia 5 2023-07-05
Reduction of hormone therapy duration in women with hormonesensitive breast cancer at very low risk of metastatic recurrence Ended

2024-514480-26-00 Post-menopausal women with localized luminal A breast c 4 2022-10-12
Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanc… Ended

2023-510097-14-00 Patients with MMR deficient relapse or advanced / metas 5 2022-04-15
A Phase 3 Study Comparing Lenalidomide and Daratumumab Subcutaneous Injection (R-Dara SC) vs Lenalidomide and Dexamethasone (Rd) in Frail Su… Ended

2024-514088-25-00 Multiple Myeloma 5 2019-10-07
Phase III randomized trial of atezolizumab in elderly patients with advanced Non-Small-Cell Lung Cancer and receiving monthly carboplatin wi… Ended

2024-515946-17-00 Non Small Cell Lung Cancer 5 2019-07-22
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, … Ended

2024-512470-10-00 End-stage Renal disease 11 2018-02-02
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection Ended

2024-510704-37-00 ER+/HER2- metastatic breast cancer 5 2017-03-22
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lun… Ended

2023-505981-26-00 Non−Small Cell Lung Cancer 5 2015-11-20
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended

2024-518741-21-00 colon cancer 4 2014-12-23
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1) Ended

2023-506253-38-00 Migraine 5 2020-11-09
Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months Ended

2024-515985-16-00 Herpes Simplex Virus Encephalitis 5 2019-04-25
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer Ended

2024-515051-38-00 Non-small Cell Lung Cancer 5 2018-07-20
Trial comparing the continuation of nivolumab and ipilimumab (doublet immunotherapy) to observation after a first 6 months treatment by nivo… Ended

2024-514586-20-01 Non small cell lung cancer 5 2018-05-02
A RANDOMIZED TRIAL TESTING EARLY VERSUS LATE ONSET OF EPO ALFA TREATMENT IN LOWER RISK MDS WITH NON RBC TRANSFUSION DEPENDENT ANEMIA AND WI… Ended

2024-515356-21-00 Adult subject (18 years of age older) with low or inter 5 2018-04-17